Background: Minimally invasive distal pancreatectomy (MIDP) has become more common in recent years, offering shorter recovery times and fewer perioperative complications compared to open surgery. However, postoperative pancreatic fistula (POPF) remains a major concern, driving the search for effective stump management strategies to minimize complications and healthcare costs.
Methods: Between February and March 2025, a 25-item Google Forms questionnaire was emailed to the lead surgeons of all 44 IGOMIPS centers. One response per center was requested. The questionnaire covered a wide range of topics, including the preferred surgical platform (laparoscopic vs robotic), types of transection devices (motorized or non-motorized staplers, energy-based tools), use of staple-line reinforcement, pre-firing compression durations, and postoperative drain-management practices. Descriptive analyses were performed and correlated with existing literature.
Results: A total of 36 invited centers, each utilizing minimally invasive surgical techniques for distal pancreatectomy, completed the survey (response rate: 81.8%, 36/44). The adopted surgical platform was robotic in 14 centers (38.9%), laparoscopic in 11 (30.6%) and mixed in 11 (30.6%). Parenchymal transection relied on motorised staplers in 24 centers (66.7%), conventional staplers in 8 (22.2%) and energy-based devices in 2 (5.6%); two centers (5.5%) tailored the device to gland thickness. Pre-firing compression lasted < 1 min in 6 centers (16.7%), 1-3 min in 16 (44.4%) and > 3 min in 6 (16.7%), while 7 centers (19.4%) had no fixed interval. Staple-line reinforcement was never used in 14 centers (38.9%), always used in 6 (16.7%) and applied selectively in the remainder. Routine prophylactic drainage was practised by 32 centers (88.9%); drains were removed < POD 5 in 14 (38.9%).
Conclusion: The marked heterogeneity in stump-management techniques in MIDP highlights the absence of robust, standardized guidelines, reflecting persistent controversies in the literature. Respondents expressed strong interest in future multicenter trials to establish evidence-based protocols, emphasizing that collaborative, large-scale research is crucial for improving patient outcomes and reducing the risk of POPF.
扫码关注我们
求助内容:
应助结果提醒方式:
